Exact Mass: 261.1399
Exact Mass Matches: 261.1399
Found 223 metabolites which its exact mass value is equals to given mass value 261.1399,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
methapyrilene
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents
cis-1,3,4,6,7,11b-Hexahydro-9-methoxy-2H-benzo[a]quinolizine-3-carboxylic acid
Serylarginine
Serylarginine is a dipeptide composed of serine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Arginylserine
Arginylserine is a dipeptide composed of arginine and serine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Lysylaspartic acid
Lysylaspartic acid is a dipeptide composed of lysine and aspartic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Aspartyllysine
Aspartyllysine is a hydrophilic dipeptide composed of aspartic acid and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. Aspartyllysine is widely distributed in nature and is present in wheat, fish, and other nutrients. It has been demonstrated to be absorbed by the intestinal H+/peptide transporter PepT1. It is excreted by the kidney-specific high-affinity H+/peptide cotransport system (PMID:1982012, 9922316, 7589991). alpha-Aspartyl-lysine is an hydrophilic dipeptide widely distributed in nature. It is present in wheat, fish and other nutrients. It has been demonstrated to be absorbed aided by the intestinal H+/Peptide transporter PepT1. It is excreted by the kidney-specific high-affinity H+/peptide cotransport system. (PMID: 1982012, 9922316, 7589991) [HMDB]
Gamma glutamyl ornithine
Gamma glutamyl ornithine is found in human urine. - PubMed reference: 1148212. Gamma-glutamylornithine has been identified in urine from patients with the HHH syndrome (hyperornithinemia, hyperammonemia and homocitrullinuria) and with gyrate atrophy associated with hyperornithinemia. The amount of gamma-glutamylornithine excreted was 10-15 times higher than that excreted in normal subjects. - PubMed reference: 6547887.
N6-beta-Aspartyllysine
N6-beta-Aspartyllysine is an unusual urinary dipeptide. This compound was observed in children in various disease states, but without any correlation with a particular symptom (PMID 618685). It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Aspartyl-Lysine
Aspartyl-Lysine is a dipeptide composed of aspartate and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Hydroxyl frovatriptan
Hydroxyl frovatriptan is a metabolite of frovatriptan. Frovatriptan (trade name Frova) is a triptan drug developed by Vernalis for the treatment of migraine headaches and for short term prevention of menstrual migraine. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe. (Wikipedia)
Thenyldiamine
Thenyldiamine is an ethylenediamine H1-antihistamine.
(2S)-2-Amino-3-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]oxypropanoic acid
Ximoprofen
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Zilpaterol
Bassiatin
A member of the class of morpholines that is morpholine-2,5-dione substituted by a benzyl, isopropyl and a methyl group at positions 3, 6 and 4 respectively. It is isolated from the culture broth of the fungus Beauveria bassiana and acts as a platelet aggregation inhibitor.
Zilpaterol
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator
(+)-6beta-benzoyloxytropan-3alpha-ol|1alphaH,5alphaH-Tropan-3alpha,6beta-diol-6-benzoat|3alpha-Hydroxy-6beta-benzoyloxytropane|6beta-benzoyloxytropan-3alpha-ol|hydroxy-3alpha benzoyloxy-6beta tropane
(+/-)-Paraensine|4-hydroxy-3-(2-hydroxy-1,2-dimethyl-propyl)-1-methyl-1H-quinolin-2-one|paraensine|Paraensine+
3alpha-(4-methoxybenzoyloxy)nortropane|merresectine A
(-)-pinolinone|(3S,4R)-3,4-dihydroxy-1-methyl-3-(3-methylbut-2-en-1-yl)-3,4-dihydroquinolin-2(1H)-one|pinolinone
7-(4-aminophenyl)-2,4-dimethyl-7-oxohept-5-enoic acid
gamma-Glu-Orn|gamma-Glutamyl-alpha-ornitine|L-L-N2-gamma-Glutamylornithine
3-(4-hydroxy-3-methoxyphenyl)-1-piperidin-1-ylprop-2-en-1-one
C15H19NO3_4-Methoxy-5-methyl-6-[(3-methyl-2-buten-1-yl)oxy]-1-isoindolinone
Asp-lys
A dipeptide formed from L-alpha-aspartyl and L-lysine residues.
Lys-asp
A dipeptide formed from L-lysine and L-aspartic acid residues.
(2S,4R)-N-BOC-4-HYDROXYPIPERIDINE-2-CARBOXYLICACIDMETHYLESTER,98\\%E.E.,95
(S)-TERT-BUTYL 4-OXO-2-PHENYLPYRROLIDINE-1-CARBOXYLATE
(S)-TERT-BUTYL 3-FORMYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXYLATE
tert-Butyl (5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methylcarbamate
(S)-2-amino-N-((S)-3-Methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-yl)propanamide
(4-OXO-CYCLOHEXYLMETHYL)-CARBAMIC ACID BENZYL ESTER
Ethyl 1-methyl-4-oxo-5-phenyl-3-piperidinecarboxylate
3-(1-Benzyl-pyrrolidin-3-yl)-3-oxo-propionic acid methyl ester
ethyl 1-benzyl-3-hydroxy-5,6-dihydro-2H-pyridine-4-carboxylate
methyl 1-(2-phenylethyl)-4-oxo-piperidine-3-carboxylate
tert-butyl 7-formyl-3,4-dihydro-2H-quinoline-1-carboxylate
ETHYL 3H-SPIRO[ISOBENZOFURAN-1,4-PIPERIDINE]-1-CARBOXYLATE
1-BENZYL-5-METHYL-4-OXO-PIPERIDINE-3-CARBOXYLIC ACID METHYL ESTER
1,1-(4-allyloxy-6-ethylamino-1,3-phenylene)diethanone
1-Piperidinecarboxylic acid, 4-ethenyl-4-hydroxy-, phenylmethyl ester
1-BENZOYL-PIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER
N-(3-aminopropyl)-1,1,2,2,3,3,4,4-octadeuteriobutane-1,4-diamine,trihydrochloride
4-(3,4-diethoxyphenyl)-3-methyl-1H-pyrazol-5-amine
1-Benzyl-3-Oxo-Piperidine-4-Carboxylic Acid Ethyl Ester
benzyl (2S)-2-(2-oxoethyl)piperidine-1-carboxylate
1-METHYL-5-AMINO-1H-BENZIMIDAZOLE-2-BUTANOIC ACID ETHYLESTER
(R)-3-FORMYL-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER
N-[3-[(2-Cyanoethyl)ethylamino]-4-methoxyphenyl]acetamide
tert-Butyl 3-formyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
1,3-PIPERIDINEDICARBOXYLIC ACID, 3-FLUORO-, 1-(1,1-DIMETHYLETHYL) 3-METHYL ESTER
9-Hydroxy-10-(propan-2-ylamino)-1,3-diazatricyclo[6.4.1.0^{4,13}]trideca-4(13),5,7-trien-2-one
1-(1,3-Benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone
(3r,11Bs)-9-methoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinoline-3-carboxylic acid
2,6-Diamino-7-(1-carboxyethylamino)-7-oxoheptanoic acid
thenyldiamine
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
ximoprofen
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
(2S)-2-Amino-3-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]oxypropanoic acid
2-Amino-5,6-dimethyl-benzimidazole-1-pentanoic acid
Thr-Ala-Ala
A tripeptide composed of L-threonine and two L-alanine units joined by peptide linkages.
8-Methyl-2-phenyl-1,2,4-triazaspiro[4.5]decane-3-thione
(2Z)-2-{[(2,5-dimethoxyphenyl)amino]methylidene}cyclohexanone
(3Z,6Z)-dodeca-3,6-dien-1-ylsulfamic acid
A member of the class of sulfamic acids that is sulfamic acid in which one of the amino hydrogens has been replaced by a (3Z,6Z)-dodeca-3,6-dien-1-yl group.
6-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hexanoate
(1E)-1-[(2-methylphenyl)hydrazinylidene]-1-morpholin-4-ylpropan-2-one
1-[(Z)-3,4-dihydro-2H-naphthalen-1-ylideneamino]-3-propan-2-ylthiourea
(5R)-5-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyhexanoate
N-(3,3-Dideutero-3-(4-methoxyphenyl)propionyl)piperidin-2-one
N-(2,2-Dideutero-3-(4-methoxyphenyl)propionyl)piperidin-2-one
N-(2,2,3,3-Tetradeutero-3-(4-methoxyphenyl)propionyl)piperidin-2-one
1,1,1,3,3,3-(Hexamethyl)-2-(trimethylsilylmethyl)trisilane
methapyrilene
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents
oscr#12(1-)
A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#12, obtained by deprotonation of the carboxy group; major species at pH 7.3.
(5e)-7-(4-aminophenyl)-2,4-dimethyl-7-oxohept-5-enoic acid
(2r,4s,5e)-7-(4-aminophenyl)-2,4-dimethyl-7-oxohept-5-enoic acid
(1ar,7r,7ar,7bs)-4-amino-1,1,7,7a-tetramethyl-1ah,6h,7h,7bh-cyclopropa[a]naphthalene-2,3,5-trione
n-{[(1r,9s)-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-11-yl]methyl}ethanimidic acid
15-methoxy-4-oxa-9-azatetracyclo[7.7.0.0¹,¹².0²,⁶]hexadeca-2(6),12-dien-3-one
3-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)prop-2-en-1-one
4-hydroxy-3-[(2r)-3-hydroxy-3-methylbutan-2-yl]-1-methylquinolin-2-one
9-[(5-hydroxy-4-methyl-2h-pyrrol-2-yl)methyl]-6-methyl-7-oxatricyclo[4.3.0.0³,⁹]nonan-8-one
4-hydroxy-3-(3-hydroxy-3-methylbutan-2-yl)-1-methylquinolin-2-one
(2e)-3-(4-hydroxy-3-methoxyphenyl)-1-(piperidin-1-yl)prop-2-en-1-one
3',5'-dimethoxy-cinnamicacid pyrrolidine
{"Ingredient_id": "HBIN007652","Ingredient_name": "3',5'-dimethoxy-cinnamicacid pyrrolidine","Alias": "NA","Ingredient_formula": "C15H19NO3","Ingredient_Smile": "COC1=CC(=CC(=C1)C=CC(=O)N2CCCC2)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6215","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
